Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | CAT | NEE |
|---|---|---|
| Price | $802.79 | $75.94 |
| Change today | ▼ 1.14% | ▼ 1.41% |
| Market cap | $369.02B | $158.40B |
| Return, 3 months | -19.1% | -12.7% |
| Return, year to date | +41.0% | -3.3% |
| Return, 1 year | +72.4% | +5.8% |
| P/E (TTM) | 34.6 | 17.1 |
| P/B | 19.0 | 2.8 |
| P/E percentile vs own 5y | 89th | 15th |
| Dividend yield | 0.75% | 3.13% |
| Revenue growth (YoY, latest qtr) | +24.0% | +12.4% |
| Net profit growth (YoY) | +64.9% | +60.0% |
| Gross margin | 32.5% | 61.0% |
| Operating margin | 17.5% | 28.3% |
| Net margin | 14.5% | 32.4% |
| Return on equity | 57.0% | 17.2% |
| Analyst target vs. price | +25.9% | +33.9% |
| Analyst buy share | 47% | 64% |
| RSI (14) | 47 | 25 |
| 30-day volatility | 29.3% | 12.2% |
| Max drawdown, 1 year | -26.7% | -19.1% |
| Trend read | Leaning bearish | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.